Exclusive Licence AgreementExclusive Licence Agreement • April 3rd, 2019 • Ascendis Pharma a/S • Pharmaceutical preparations • Delaware
ContractShareholders Agreement • April 3rd, 2019 • Ascendis Pharma a/S • Pharmaceutical preparations • Hong Kong
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
ContractAscendis Pharma a/S • April 3rd, 2019 • Pharmaceutical preparations
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
ContractManufacturing and Supply Agreement • April 3rd, 2019 • Ascendis Pharma a/S • Pharmaceutical preparations
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
SUPPLY AGREEMENT for manufacture and supply of dual-chamber cartridges [***], pre-filled with TransCon [***] hGH and Water for Injection, delivered [***] effective as of January 1st, 2019 by and between ASCENDIS PHARMA A/S and VETTER PHARMA...Quality Agreement • April 3rd, 2019 • Ascendis Pharma a/S • Pharmaceutical preparations
THIS SUPPLY AGREEMENT, made and entered into as of the date written above (hereinafter, this “Agreement”), by and between Ascendis Pharma A/S, a company duly organized and existing under the laws of Denmark and having its place of business located at Tuborg Boulevard 12, 2900 Hellerup, Denmark (“Ascendis”), and Vetter Pharma International GmbH, a company duly organized and existing under the laws of Germany, having its principal place of business at Eywiesenstraße 5, 88212 Ravensburg, Germany (“Vetter International”) and owned 100% by Vetter Pharma-Fertigung GmbH & Co. KG (“Vetter Pharma”),
